COMPANY PROFILE

Bluebee

Explore full profile

Bluebee offers a secure global bio-informatics platform to process, analyze, share and store genomics data

Rijswijk, NetherlandsFounded 2011Biotech & Life Sciences

Valuation $50–100M Last recorded · 2016

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Bluebee

Bluebee is a leading provider of advanced genomic data analysis solutions designed to support precision medicine and research applications. The company operates in the biotechnology and healthcare markets, serving clients such as research institutions, healthcare providers, and pharmaceutical companies. Bluebee's business model revolves around offering cloud-based platforms that enable the efficient processing, storage, and interpretation of genomic data. This allows clients to gain valuable insights from complex genetic information, facilitating advancements in personalized medicine and scientific research. The company generates revenue through subscription fees for its platform services and customized solutions tailored to specific client needs. Bluebee's commitment to innovation and quality ensures that it remains at the forefront of the genomic data analysis industry.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2011
Headquarters: Rijswijk, Netherlands
Employees: 21
Open positions: None listed
Dealroom signal: 74.0/100
Industry: Health, Enterprise Software
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Open Source, Analytics, Biotechnology, Genetics and genomics, Spinout, Genome Engineering, DT and LS, science-based
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Jun 2020	$0	—	Illumina	—
SERIES A✓Equity / VC	Mar 2016	$11M	$44M	Capricorn Partners · Korys · Buysse & Partners	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Bluebee website traffic

Latest recorded traffic for Bluebee is 160 monthly website visits, up 433.3% over the last three months. Bluebee's team declined 4.5% over the past year.

Latest monthly visits160 3-month web change+433.3% 1-year team growth-4.5%

Monthly website visitsOct 2014–May 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
1D1928 DiagnosticsAn easy-to-use software service for microbiology labs translating DNA into actionable results	Göteborgs Stad, Sweden	Operational	12	$4.5M	$1.3M
COCongenicaClinical genomics analytics platform	Hinxton, United Kingdom	Acquired
UGUgenTecData analytics software for lab technicians	Hasselt, Belgium	Acquired
LILifebitEmpowers therapeutic leaders and pioneers in precision medicine on how to access and analyse siloed biomedical data	London, United Kingdom	Operational
FGFabric GenomicsGlobal healthcare platform for genomic data analysis - Formerly Omicia	San Francisco, United States	Acquired
EGEagle GenomicsDeveloping life sciences smart data management and analysis solutions	Cambridge, United Kingdom	Operational
BIBiomodalSimultaneous genetic and epigenetic sequencing from single samples	Cambridge, United Kingdom	Operational
TWtwoXARImproving Health Through Computation	Palo Alto, United States	Operational